Your browser doesn't support javascript.
loading
Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variants.
Cline, Melissa S; Babbi, Giulia; Bonache, Sandra; Cao, Yue; Casadio, Rita; de la Cruz, Xavier; Díez, Orland; Gutiérrez-Enríquez, Sara; Katsonis, Panagiotis; Lai, Carmen; Lichtarge, Olivier; Martelli, Pier L; Mishne, Gilad; Moles-Fernández, Alejandro; Montalban, Gemma; Mooney, Sean D; O'Conner, Robert; Ootes, Lars; Özkan, Selen; Padilla, Natalia; Pagel, Kymberleigh A; Pejaver, Vikas; Radivojac, Predrag; Riera, Casandra; Savojardo, Castrense; Shen, Yang; Sun, Yuanfei; Topper, Scott; Parsons, Michael T; Spurdle, Amanda B; Goldgar, David E.
Afiliação
  • Cline MS; Genomics Institute, UC Santa Cruz, Santa Cruz, California.
  • Babbi G; FaBiT Department, Biocomputing Group, University of Bologna, Bologna, Italy.
  • Bonache S; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Cao Y; Department of Electrical and Computer Engineering, Texas A&M University, College Station, Texas.
  • Casadio R; FaBiT Department, Biocomputing Group, University of Bologna, Bologna, Italy.
  • de la Cruz X; Clinical and Translational Bioinformatics Research Unit, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Díez O; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
  • Gutiérrez-Enríquez S; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Katsonis P; Clinical and Translational Bioinformatics Research Unit, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Lai C; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Lichtarge O; Department of Medical and Human Genetics, Baylor College of Medicine, Houston, Texas.
  • Martelli PL; Color Genomics, Burlingame, California.
  • Mishne G; Department of Medical and Human Genetics, Baylor College of Medicine, Houston, Texas.
  • Moles-Fernández A; Department of Biochemistry & Molecular Biology, Baylor College of Medicine, Houston, Texas.
  • Montalban G; Department of Pharmacology, Baylor College of Medicine, Houston, Texas.
  • Mooney SD; Computational and Integrative Biomedical Research Center, Baylor College of Medicine, Houston, Texas.
  • O'Conner R; FaBiT Department, Biocomputing Group, University of Bologna, Bologna, Italy.
  • Ootes L; Color Genomics, Burlingame, California.
  • Özkan S; Clinical and Translational Bioinformatics Research Unit, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Padilla N; Clinical and Translational Bioinformatics Research Unit, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Pagel KA; Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington.
  • Pejaver V; Sage Bionetworks, Seattle, Washington.
  • Radivojac P; Clinical and Translational Bioinformatics Research Unit, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Riera C; Clinical and Translational Bioinformatics Research Unit, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Savojardo C; Clinical and Translational Bioinformatics Research Unit, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Shen Y; Computer Science and Informatics, Indiana University, Bloomington, Indiana.
  • Sun Y; Biomedical Informatics and Medical Education, University of Washington, Seattle, Washington.
  • Topper S; Computer Science and Informatics, Indiana University, Bloomington, Indiana.
  • Parsons MT; Khoury College of Computer Science, Northeastern University, Boston, Massachusetts.
  • Spurdle AB; Clinical and Translational Bioinformatics Research Unit, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Goldgar DE; FaBiT Department, Biocomputing Group, University of Bologna, Bologna, Italy.
Hum Mutat ; 40(9): 1546-1556, 2019 09.
Article em En | MEDLINE | ID: mdl-31294896
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Proteína BRCA1 / Biologia Computacional / Proteína BRCA2 Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Hum Mutat Assunto da revista: GENETICA MEDICA Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / Proteína BRCA1 / Biologia Computacional / Proteína BRCA2 Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Revista: Hum Mutat Assunto da revista: GENETICA MEDICA Ano de publicação: 2019 Tipo de documento: Article